<i>K-ras</i> Mutations and Benefit from Cetuximab in Advanced Colorectal CancerChristos S. Karapetis, John Zalcberg, Heather‐Jane Au et al.|New England Journal of Medicine|2008Cited by 3.6k
Cetuximab for the Treatment of Colorectal CancerDerek J. Jonker, Malcolm J. Moore, Chris J. O’Callaghan et al.|New England Journal of Medicine|2007Cited by 1.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C MutationFerdinandos Skoulidis, Ramaswamy Govindan, Bob T. Li et al.|New England Journal of Medicine|2021Cited by 1.8k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision makingHans‐Joachim Schmoll, Andrés Cervantes, Eric Van Cutsem et al.|Annals of Oncology|2012Cited by 1.5k
Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancerJeanne Tie, Peter Gibbs, Yuxuan Wang et al.|Science Translational Medicine|2016Cited by 1.5k